FAX Capital Corp.

Insider profile

Performance

Overall performance
2.4

Performance over holding periods
2.4
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 36% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
FAX Capital Corp.'s trades of Biosyent Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
243.26
Quantity 39,658 -5.5%
Value CA$2,560,803
Transaction date
Sale
Price
484.29
Quantity 46,292 -47.9%
Value CA$563,053
Transaction date
Sale
Price
208.25
Quantity 55,640 -33.9%
Value CA$4,500,750
Transaction date
Sale
Price
10.05
Quantity 500,000 -23.3%
Value CA$5,025,000
Transaction date
Sale
Price
7.70
Quantity 65,000 -3.0%
Value CA$500,500
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-01-06 2025-01-06 S Sale
39,658 -5.5%
243.26
CA$2,560,803
39,658 -5.5% 243.26 CA$2,560,803
2024-12-23 2024-12-23 S Sale
46,292 -47.9%
484.29
CA$563,053
46,292 -47.9% 484.29 CA$563,053
2024-12-04 2024-12-04 S Sale
55,640 -33.9%
208.25
CA$4,500,750
55,640 -33.9% 208.25 CA$4,500,750
2024-09-03 2024-07-23 S Sale
500,000 -23.3%
10.05
CA$5,025,000
500,000 -23.3% 10.05 CA$5,025,000
2024-11-26 2023-04-13 S Sale
65,000 -3.0%
7.70
CA$500,500
65,000 -3.0% 7.70 CA$500,500